Startups
IDRx is a clinical-stage biopharmaceutical company dedicated to transforming cancer care with intelligently designed precision therapies. IDRx aims to address the limitations of today’s precision cancer medicines with highly potent and selective targeted therapies to stop key tumor escape mechanisms and prolong response to therapy.
Summary
Investors
- RA Capital Management Series B
- RA Capital Management Series B
- Blackstone Group Series B
- Commodore Capital Series B
Full Company Profile
- Access details of the company management, and other intelligence on this company by registering for Seedtable